NA Nano Labs Ltd

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2024

 

Commission File Number: 001-41426

 

Nano Labs Ltd

(Exact name of registrant as specified in its charter)

 

China Yuangu Hanggang Technology Building

509 Qianjiang Road, Shangcheng District,

Hangzhou, Zhejiang, 310000

People’s Republic of China

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒        Form 40-F ☐

 

 

 

Interim Condensed Balance Sheet as of September 30, 2024

 

Nano Labs Ltd (the “Company”) sets forth the preliminary unaudited condensed balance sheet as of September 30, 2024, which have been prepared by, and are the responsibility of, the Company’s management. The preliminary financial data are based on the information currently available to us as of the date of this report.

 

Nano Labs Ltd

Consolidated Balance Sheets

(Unaudited)

 

		As of Sept 30,				As of Sept 30,
		2024				2024
		RMB				US$*
ASSETS
Current assets:
Cash and cash equivalents			50,322,415				7,181,325
Restricted cash			418,201				59,680
Accounts receivable, net			2,178,747				310,921
Inventories, net			10,191,230				1,454,353
Prepayments			24,155,244				3,447,105
Other current assets			52,524,971				7,495,643
Total current assets			139,790,808				19,949,026
Non-current assets:
Property, plant and equipment, net			197,476,913				28,181,196
Intangible asset, net			46,991,905				6,706,040
Operating lease right-of-use assets			7,028,136				1,002,959
Total non-current assets			251,496,954				35,890,195
TOTAL ASSETS			391,287,762				55,839,222
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term debts			20,000,000				2,854,126
Current portion of long-term debts			4,580,000				653,595
Accounts payable			12,481,588				1,781,201
Advance from customers			83,505,919				11,916,819
Operating lease liabilities, current			2,877,067				410,576
Other current liabilities			70,839,217				10,109,201
Total current liabilities			194,283,792				27,725,518
Non-current liabilities:
Long-term debts			169,833,636				24,236,327
Operating lease liabilities, non-current			3,938,711				562,079
Total non-current liabilities			173,772,347				24,798,406
Total liabilities			368,056,139				52,523,923
Shareholders' equity :
Class A ordinary shares			100,584				14,354
Class B ordinary shares			36,894				5,265
Additional paid-in capital			531,220,288				75,808,472
Accumulated deficit			(519,783,722	)			(74,176,402	)
Statutory reserves			6,647,109				948,584
Accumulated other comprehensive income			5,010,470				715,026
Total Nano Labs Ltd shareholders' equity			18,516,603				2,642,436
Noncontrolling interests			4,715,020				672,863
Total shareholders' equity			23,231,623				3,315,299
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY			391,287,762				55,839,222

 

*

Convenient translation rate is US$1 = RMB7.0074

 

 

In accordance with Nasdaq Listing Rule 5550(b)(1), the Company is required to maintain a minimum of $2.5 million in stockholders’ equity for continued listing on The Nasdaq Capital Market. Based on the financial statements for the six months ended/as of June 30, 2024, as disclosed by the Company on September 18, 2024, the Company had fallen below this requirement.

 

During the three months ended September 30, 2024, the Company entered into agreements with Mr. Jianping Kong, its chairman and chief executive officer, and Mr. Qifeng Sun, its vice chairman, along with their respective affiliates (the “Lenders”) on September 20, 2024, to convert the interest-free loans from the Lenders in an aggregated amount of US$8.5 million into certain amount of Class A ordinary shares (the “Conversion”) in lieu of repayment of the Loans. The Conversion has been closed on September 23, 2024. This transaction has strengthened the Company’s financial position and increased its stockholders’ equity. As of the date the Company furnished this report, the Company reasonably believes it is compliant with Nasdaq Capital Market’s minimum stockholders' equity requirement of $2.5 million as a result of the aforementioned transaction.

 

The Company acknowledges that Nasdaq will continue to monitor its ongoing compliance with the stockholders’ equity requirement. If at the time of its next periodic report the Company does not evidence compliance with this requirement, it may be subject to delisting from The Nasdaq Capital Market.

 

This report on Form 6-K is hereby incorporated by reference into the Company’s Registration Statement on Form F-3, as amended, initially filed with the U.S. Securities and Exchange Commission (the “SEC”) on August 14, 2023 (Registration No. 333-273968) and a prospectus supplement dated April 11, 2024 thereunder, and shall be a part thereof from the date on which this current report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

 

Forward-Looking Statements

 

This report contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, the Company’s compliance with the relevant Nasdaq continued listing standards, which can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause the Company’s compliance status, actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	Nano Labs Ltd
Date: November 21, 2024	By:	/s/ Jianping Kong
	Name:	Jianping Kong
	Title:	Chairman and Chief Executive Officer

 

 

3

 

---